Imagion Biosystems has breast cancer technology qualified as a breakthrough device - Proactive Investors Australia

Imagion Biosystems has breast cancer technology qualified as a breakthrough device  Proactive Investors AustraliaImagion Biosystems Ltd (ASX:IBX) - The MagSense test aims to eliminate the unnecessary surgeries and concomitant morbidity resulting from the standard of ...